One important key to faster growth is brain power. Madison has benefited from the intellectual gold mine at the University of Wisconsin-Madison, the nations third-largest research university. Some of the states fastest-growing companies grew out of UW research, including TomoTherapy, which went public in May, and NimbleGen Systems Inc., which was acquired by the Swiss pharmaceutical giant Roche Holding AG. Then, there is Cellectar, which develops technology that tracks and destroys tumors. It is run by a UW-Madison professor and a former executive at GE Healthcare.
Office of Strategic Communication